General Information
-
DRAMP ID
- DRAMP04654
-
Peptide Name
- H-0, Hymenochirin-1B
-
Source
- Hymenochirus boettgeri (Congo dwarf clawed frog)
-
Family
- Unknown
-
Gene
- Not found
-
Sequence
- IKLSPETKDNLKKVLKGAIKGAIAVAKMV
-
Sequence Length
- 29
-
UniProt Entry
- No entry found
-
Protein Existence
- Experimental evidence at transcript level
Activity Information
-
Biological Activity
- Antimicrobial, Anticancer
-
Target Organism
-
- [Ref.30789695] Cancer cell lines: A549 (IC50 = 15.22 ± 0.21 μM), HCT116 (IC50 = 12.76 ± 0.43 μM), HepG2 (IC50 = 8.07 ± 0.21 μM)
-
Hemolytic Activity
-
- [Ref.30789695] It has 5%, 6.3%, 7.7%, 10%, 10.7%, 15.3%, 9%, 15% and 9.7% hemolysis against fresh rabbit blood cells at 0.010, 0.25, 0.5, 1.0, 2.0, 5.0, 10.0, 20.0, 25.0μM
-
Cytotoxicity
- No cytotoxicity information found in the reference(s) presented
-
Binding Target
- Not found
Structure Information
-
Linear/Cyclic
- Linear
-
N-terminal Modification
- Free
-
C-terminal Modification
- Amidation
-
Nonterminal Modifications and Unusual Amino Acids
- None
-
Stereochemistry
- L
-
Structure
- α-helical (most likely)
-
Structure Description
- No detailed structure description found.
-
Helical Wheel Diagram
-
PDB ID
- None
-
Predicted Structure
- Please click DRAMP04654_predicted_structure.pdb to download.
Physicochemical Information
-
Formula
- C139H251N37O37S
Absent Amino Acids
- CFHQRWY
Common Amino Acids
- K
Mass
- 3064.81
PI
- 10.13
Basic Residues
- 7
Acidic Residues
- 2
Hydrophobic Residues
- 13
Net Charge
- +5
-
Boman Index
- -13.88
Hydrophobicity
- 0.169
Aliphatic Index
- 124.48
Half Life
-
- Mammalian:20 hour
- Yeast:30 min
- E.coli:>10 hour
Extinction Coefficient Cystines
- 0
Absorbance 280nm
- 0
Polar Residues
- 5
DRAMP04654
Comments Information
Function
- Antimicrobial, Anticancer, Immunomodulatory and Antidiabetic activity.
As a cationic, amphipathic, α-helical, 29-residue,host defense peptide, Hymenochirin-1B is the predominant pharmacological active component of four hymenochirins, which showed a wide range of biological activities, such as antimicrobial, anticancer, immunomodulatory, and antidiabetic activities. Surprisingly, we don't find the entry introducing Hymenochirin-1B in UniProt (2021-3-29).
Literature Information
- ·Literature 1
-
Title
- Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy
-
Pubmed ID
- 30789695
-
Reference
- ACS Chem Biol. 2019 Mar 15;14(3):516-525. doi: 10.1021/acschembio.9b00046. Epub 2019 Mar 1.
-
Author
- Yulei Li, Yihan Zhang, Minghao Wu, Qi Chang, Honggang Hu, Xia Zhao